{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:03Z","timestamp":1792081503754,"version":"4.4.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is characterized by growth hormone deficiency (GHd). We investigated the association between NAFLD and GHd in patients with nonfunctioning pituitary adenomas (NFPA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>We recruited patients with NFPA who underwent transsphenoidal adenectomy between January 2005 and December 2018. Pituitary function was determined by the insulin tolerance test, thyroid hormone assay, and gonadal hormone levels. NAFLD was defined as a hepatic steatosis index greater than 36.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 278 patients (mean age, 44.2 years; 58.6% [n=163] female), 103 (37.0%) had GHd, 139 (50.0%) had hypogonadism, and 75 (27.0%) had NAFLD. The prevalence of NAFLD was significantly higher in patients with GHd than in those without (36.9% vs. 21.1%, p=0.01). Even after adjusting for age, total cholesterol level, gonadal function, and prolactin level, patients with GHd had approximately two-fold higher prevalence of NALFD than those without GHd (adjusted odds ratio [OR]=1.85, 95% confidence interval [CI]=1.05\u20133.28, p=0.03). Among female patients, the prevalence of NALFD was significantly higher in those with GHd than in those without (adjusted OR=2.39, 95% CI=1.03\u20135.55, p=0.04); whereas, among male patients, the prevalence of NAFLD was statistically similar between those with and without GHd (p&amp;gt;0.05). In addition, gonadal function did not affect the prevalence of NAFLD in patients with NFPA (29.3% with eugonadism vs. 47.8% with hypogonadism, p=0.14).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among patients with NFPA, the prevalence of NAFLD was two-fold higher in patients with GHd than that in those without GHd. Thus, screening for NAFLD might be required in NFPA patients with GHd.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1057769","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T12:20:14Z","timestamp":1673353214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Yoon-a","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2009.084","article-title":"Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics","volume":"64","author":"Haentjens","year":"2009","journal-title":"Acta Clin Belg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0239","article-title":"Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"27","author":"Wijarnpreecha","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3350\/cmh.2020.0067","article-title":"Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH","volume":"26","author":"Hydes","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00335","article-title":"Relationship between hypothyroidism and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"8","author":"He","year":"2017","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.4.372","article-title":"Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study","volume":"21","author":"Lee","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","article-title":"Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis","volume":"13","author":"Lazo","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0030-1265217","article-title":"Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men","volume":"43","author":"Hong","year":"2011","journal-title":"Horm Metab Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2020.1867094","article-title":"Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: A prospective controlled registry study","volume":"23","author":"Yassin","year":"2020","journal-title":"Aging Male."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5604\/16652681.1235481","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.815995","article-title":"J-Shaped relationship between serum prolactin and metabolic-associated fatty liver disease in female patients with type 2 diabetes","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/cells10102532","article-title":"Towards understanding the direct and indirect actions of growth hormone in controlling hepatocyte carbohydrate and lipid metabolism","volume":"10","author":"Vazquez-Borrego","year":"2021","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2008.03.003","article-title":"Nonalcoholic fatty liver in patients with laron syndrome and GH gene deletion - preliminary report","volume":"18","author":"Laron","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/ijms18071447","article-title":"The role of growth hormone and insulin-like growth factor-I in the liver","volume":"18","author":"Takahashi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.77","article-title":"Diagnosis and treatment of growth hormone deficiency in adults","volume":"9","author":"Kargi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.024","article-title":"Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency","volume":"132","author":"Takahashi","year":"2007","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.914","article-title":"Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency","volume":"52","author":"Ichikawa","year":"2003","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i14.1741","article-title":"Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients","volume":"25","author":"Yuan","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2014.07.002","article-title":"Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency","volume":"24","author":"Matsumoto","year":"2014","journal-title":"Growth Horm IGF Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-124970","article-title":"Reduced growth hormone secretion is associated with nonalcoholic fatty liver disease in obese children","volume":"50","author":"Liang","year":"2018","journal-title":"Horm Metab Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04291.x","article-title":"Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH\/IGF-I levels","volume":"77","author":"Fusco","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8814435","article-title":"Characteristics of NAFLD based on hypopituitarism","volume":"2020","author":"Kodama","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20140","article-title":"Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction","volume":"39","author":"Adams","year":"2004","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cen.13042","article-title":"Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement","volume":"85","author":"Meienberg","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021897","article-title":"Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease","volume":"88","author":"Schmidt","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","first-page":"574","article-title":"Clifford Rosen, Richard Auchus, Allison goldfine","volume-title":"Williams textbook of endocrinology","author":"Bulun","year":"2020"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19301","article-title":"Hepatic steatosis index in the detection of fatty liver in patients with chronic hepatitis b receiving antiviral therapy","volume":"15","author":"Chang","year":"2021","journal-title":"Gut Liver."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0537","article-title":"GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism","volume":"152","author":"Barclay","year":"2011","journal-title":"Endocrinology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/EJE-12-0002","article-title":"Hepatic steatosis, GH deficiency and the effects of GH replacement: A Liverpool magnetic resonance spectroscopy study","volume":"166","author":"Gardner","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0370","article-title":"Growth hormone inhibits hepatic De novo lipogenesis in adult mice","volume":"64","author":"Cordoba-Chacon","year":"2015","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.12.014","article-title":"Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity","volume":"51","author":"Lonardo","year":"2019","journal-title":"Dig Liver Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00060","article-title":"Activation of Male liver chromatin accessibility and STAT5-dependent gene transcription by plasma growth hormone pulses","volume":"158","author":"Connerney","year":"2017","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02835-6","article-title":"Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy","volume":"74","author":"Rossini","year":"2021","journal-title":"Endocrine"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2016.57.3.674","article-title":"Visceral fat mass has stronger associations with diabetes and prediabetes than other anthropometric obesity indicators among Korean adults","volume":"57","author":"Jung","year":"2016","journal-title":"Yonsei Med J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187066","article-title":"The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0447","article-title":"Hepatocyte-specific, PPARgamma-regulated mechanisms to promote steatosis in adult mice","volume":"232","author":"Wolf Greenstein","year":"2017","journal-title":"J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-Dependent NASH and STAT-3-Dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01844","article-title":"Age- and sex-specific differences as predictors of surgical remission among patients with acromegaly","volume":"103","author":"Park","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02676.x","article-title":"Modulation of growth hormone action by sex steroids","volume":"65","author":"Meinhardt","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","article-title":"Sex steroids and the GH axis: Implications for the management of hypopituitarism","volume":"31","author":"Birzniece","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09605-1","article-title":"Individual sensitivity to growth hormone replacement in adults","volume":"22","author":"Boguszewski","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2008.07.001","article-title":"The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women","volume":"19","author":"Franco","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"Volzke","year":"2007","journal-title":"Gut"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2174\/1570161116666180711121949","article-title":"Menopause and non-alcoholic fatty liver disease: A review focusing on therapeutic perspectives","volume":"17","author":"Venetsanaki","year":"2019","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1057769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T12:20:18Z","timestamp":1673353218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1057769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":54,"alternative-id":["10.3389\/fendo.2022.1057769"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1057769","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1057769"}}